Main Menu
Menu

Resources

Publish Date
Resources
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: U.S. Patent and Trademark Office
Resources
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on China and IP Theft
Resources
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Resources
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Resources
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025
Resources
Letters
C4IP Letter to USTR RE: US-EU Trade Agreement
Resources
Public Comments
C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025)
Resources
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Resources
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Resources
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
C4IPResources
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Resources
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing
Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Medication Affordability and Patent Integrity Act,

08/26/2024
Resources:

Resources:

C4IP Comments RE: The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044),

07/29/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: IP Litigation and the U.S. International Trade Commission,

07/22/2024
Resources:

Resources:

C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003),

07/09/2024
Resources:

Resources:

C4IP Comments RE: Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (PTO-P-2023-0048),

06/18/2024
Resources:

Resources:

C4IP Comments RE: Rules Governing Director Review of Patent Trial and Appeal Board Decisions (PTO-P-2024-0014),

06/17/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: SHOP SAFE Act,

06/13/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: Third-Party Litigation Funding,

06/12/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: The PREVAIL Act,

06/10/2024
Resources:

Resources:

C4IP Comments RE: Setting and Adjusting Patent Fees During Fiscal Year 2025 (PTO-P-2022-0033),

06/03/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: May 21, 2024 Hearing on Drug Prices,

05/20/2024
Resources:

Resources:

C4IP Letter to Senate Commerce, Science, & Transportation Committee RE: The Invent Here, Make Here Act of 2023,

05/15/2024
Scroll to Top